Pharmacokinetic study of Benralizumab in Healthy Chinese Subjects

Trial Identifier: D3250C00034
Sponsor: AstraZeneca
NCTID:: NCT03928262
Start Date: April 2019
Primary Completion Date: August 2019
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Traditional Chinese Translation

Trial Locations

Country Location
Hong Kong Hong Kong, Hong Kong, NA